menu
    • menu

    Company profile for VenatoRx Pharmaceuticals

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    VenatoRx is a private pharmaceutical company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant bacterial infections and hard-to-treat viral infections. The company name, VenatoRx (ven-a-TOREX), derives from the Latin word “venator”, meaning ‘hunter’ and “Rx”, the medical symbol for drugs. The pursuit, or “hunt”, for new drugs is the core mission of our compa...
    VenatoRx is a private pharmaceutical company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant bacterial infections and hard-to-treat viral infections. The company name, VenatoRx (ven-a-TOREX), derives from the Latin word “venator”, meaning ‘hunter’ and “Rx”, the medical symbol for drugs. The pursuit, or “hunt”, for new drugs is the core mission of our company. Founded in 2010, VenatoRx has built a world-class in-house R&D organization that has filed over 100 patents spanning multiple research programs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VenatoRx PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    74 E. Swedesford Road, Suite 100 Malvern, PA 19355
    Telephone
    Telephone
    610-644-8935
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.venatorx.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/venatorx-pharmaceuticals-inc.
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/venatorxpharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tiger Group And EquipNet Auction Scientific Equipment On Oct. 16
    Tiger Group And EquipNet Auction Scientific Equipment On Oct. 16

    08 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scientific-equipment-goes-to-auction-in-tiger-group-and-equipnet-sale-on-oct-16-302578031.html

    PR NEWSWIRE
    08 Oct 2025
    Share Share
    Basilea Secures BARDA Contract For Ceftibuten-Ledaborbactam
    Basilea Secures BARDA Contract For Ceftibuten-Ledaborbactam

    25 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/25/3155972/0/en/Basilea-awarded-BARDA-contract-for-the-development-of-novel-oral-phase-3-ready-antibiotic-ceftibuten-ledaborbactam.html

    GLOBENEWSWIRE
    25 Sep 2025
    Share Share
    Venatorx Pharmaceuticals Announces Changes to Executive Leadership
    Venatorx Pharmaceuticals Announces Changes to Executive Leadership

    16 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240516929135/en

    BUSINESSWIRE
    16 May 2024
    Share Share
    Venatorx Pharmaceuticals Expands Senior Leadership Team
    Venatorx Pharmaceuticals Expands Senior Leadership Team

    12 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240312282344/en

    BUSINESSWIRE
    12 Mar 2024
    Share Share
    Venatorx and Melinta Provide Update on Status of NDA for Cefepime-Taniborbactam
    Venatorx and Melinta Provide Update on Status of NDA for Cefepime-Taniborbactam

    23 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240223169844/en

    BUSINESSWIRE
    23 Feb 2024
    Share Share
    New England Journal of Medicine Publishes Positive Results of Cefepime-Taniborbactam from Phase 3
    New England Journal of Medicine Publishes Positive Results of Cefepime-Taniborbactam from Phase 3

    20 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240220917017/en

    BUSINESSWIRE
    20 Feb 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search